Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
作者： Joan H. Schiller , David Harrington , Chandra P. Belani , Corey Langer , Alan Sandler
DOI: 10.1056/NEJMOA011954
关键词: Regimen 、 Medicine 、 Docetaxel 、 Oncology 、 Internal medicine 、 Necitumumab 、 Lung cancer 、 Survival rate 、 Carboplatin 、 Chemotherapy 、 Gemcitabine
摘要: … Chemotherapy for advanced non–small-cell lung cancer is often … care, chemotherapy results in a small improvement in survival in patients with advanced non–small-cell lung cancer. In …
elsevier.com
elsevier.es参考文章(16)
M. H. Cullen, L. J. Billingham, C. M. Woodroffe, A. D. Chetiyawardana, N. H. Gower, R. Joshi, D. R. Ferry, R. M. Rudd, S. G. Spiro, J. E. Cook, C. Trask, E. Bessell, C. K. Connolly, J. Tobias, R. L. Souhami, Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life Journal of Clinical Oncology. ,vol. 17, pp. 3188- 3194 ,(1999) , 10.1200/JCO.1999.17.10.3188
C J Langer, J C Leighton, R L Comis, P J O'Dwyer, C A McAleer, C A Bonjo, P F Engstrom, S Litwin, R F Ozols, Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. Journal of Clinical Oncology. ,vol. 13, pp. 1860- 1870 ,(1995) , 10.1200/JCO.1995.13.8.1860
J Klastersky, J P Sculier, G Bureau, P Libert, P Ravez, G Vandermoten, J Thiriaux, J Lecomte, R Cordier, G Dabouis, Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium. Journal of Clinical Oncology. ,vol. 7, pp. 1087- 1092 ,(1989) , 10.1200/JCO.1989.7.8.1087
Diane Fairclough, David Cella, John Kugler, Eric Rowinsky, Michael Jiroutek, David Johnson, Philip Bonomi, KyungMann Kim, Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial Journal of Clinical Oncology. ,vol. 18, pp. 623- 631 ,(2000) , 10.1200/JCO.2000.18.3.623
P D Bonomi, D M Finkelstein, J C Ruckdeschel, R H Blum, M D Green, B Mason, R Hahn, D C Tormey, J Harris, R Comis, Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. ,vol. 7, pp. 1602- 1613 ,(1989) , 10.1200/JCO.1989.7.11.1602
R Grilli, A D Oxman, J A Julian, Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? Journal of Clinical Oncology. ,vol. 11, pp. 1866- 1872 ,(1993) , 10.1200/JCO.1993.11.10.1866
E Rapp, J L Pater, A Willan, Y Cormier, N Murray, W K Evans, D I Hodson, D A Clark, R Feld, A M Arnold, Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. Journal of Clinical Oncology. ,vol. 6, pp. 633- 641 ,(1988) , 10.1200/JCO.1988.6.4.633
R.P. Abratt, W.R. Bezwoda, L. Goedhals, D.J. Hacking, 1086 A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer European Journal of Cancer. ,vol. 31, pp. S226- ,(1995) , 10.1016/0959-8049(95)96332-8
Pietro Marino, Sandro Pampallona, Armando Preatoni, Alessandra Cantoni, Fulvio Invernizzi, Chemotherapy vs Supportive Care in Advanced Non-Small-Cell Lung Cancer Chest. ,vol. 106, pp. 861- 865 ,(1994) , 10.1378/CHEST.106.3.861
L. Crinò, G. Seagliotti, M. Marangolo, F. Figoli, M. Clerici, F. De Marinis, F. Salvati, G. Cruciani, L. Dogliotti, G. Cocconi, A. Paccagnella, V. Adamo, P. Incoronato, L. Scarcella, A.M. Mosconi, M. Tonato, 1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study European Journal of Cancer. ,vol. 31, pp. S222- ,(1995) , 10.1016/0959-8049(95)96311-Z